SSA
CLCD

Schonfeld Strategic Advisors’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,240
Closed -$591K – 831
2016
Q4 		$591K Buy
+16,240
New +$575K 0.08% 308

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Schonfeld Strategic Advisors's CLCD Position: Q1 2017 in Review

Schonfeld Strategic Advisors sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 16,240 shares — an estimated $591K sold.

Schonfeld Strategic Advisors first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $591K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Schonfeld Strategic Advisors reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 16,240 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $591K.
  • Schonfeld Strategic Advisors first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's CoLucid Pharmaceuticals, Inc. position peaked at $591K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.